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Abstract
Streptococcus (S.) uberis is a causative agent for clinical and subclinical bovine mastitis which significance for the
udder health has increased over the last decades. Molecular diagnosis methods revealed that S. uberis may be
subdivided into many different varieties with different epidemiological properties. In addition, some varieties were re-
classified as Streptococcus parauberis and Globicatella sanguinis. The present paper reviews S. uberis and its role
in modern dairy farming. This pathogen is ubiquitous for which it is considered as environment-associated. Straw
bedding and pasture, but also the bovine skin and digestive mucosae are typical localizations inhabited by S. uberis.
Due to its capacity to persist within the mammary tissue, some infections may eventually turn cow-associated. In
other cases, the infection is short, but in any case, there is a high risk of re-infection. Although many varieties remain
susceptible to most antimicrobial agents, the problem for the dairy farm lies in the high rate of re-infection. This
paper also reviews risk factors, therapies and measures to control S. uberis at farm level.
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Introduction
Mastitis caused by Streptococcus (S.) uberis has been detected
increasingly in dairy farms. This species is known to cause both
clinical and subclinical infections of the bovine udder and represents
the leading pathogen in a growing amount of dairy herds.
The present paper is intended as a literature review regarding the
properties, the ways of diagnosis and the possible strategies to combat
this microorganism. The more risk factors that favour the
development of the disease are known, the more efficient advice can be
provided to the farmer.
Properties and diagnosis
S. uberis [1] is classified within the order Lactobacillales and the
family Streptococcaceae. There have been many ways to classify
streptococci. One of the first was the Lancefield grouping which is
based on serology, In the original paper [2], S. uberis (which was
described in 1932) was not mentioned expressedly, but all
corresponding strains (group E) originated from bovine milk.
However, not all S. uberis strain can be classified as group E, so that
other authors [3] consider it as a part of group G. Many Lancefield
groups (including E) were later merged to a “pyogenic group”, along
with other typical animal pathogens, e.g. S. dysgalactiae, S. agalactiae,
S. canis, and S. equi [4]. Nowadays, molecular biology methods, e.g.
DNA-DNA reassociation or 16S rDNA gene sequencing, are used to
classify the different species. S. uberis, which also belongs to the
pyogenic group, acts as the sister clade to the species mentioned
before, as was demonstrated by Täpp et al. [5] who sequenced the
RNase P RNA gene rnpB. From the clinical point of view, Facklam [4]
chose another way of classification which is based on phenotype. Being
human-based, S. uberis was classified as an “unusual Streptococcus
species”.
The bacterium is Gram-positive, aerotolerant and anaerobial. The
cells are coccoid (diameter 0.5 to 1 µm) and occur in pairs or in chains.
On blood agar plates, S. uberis grows at 30 to 37°C. Colonies have a
diameter of 1 to 2 mm after an incubation period of 24 to 48 h.
Providing 0.1% aesculin to the medium enhances bacteria
identification, as S. uberis and enterococci hydrolyse aesculin to
glucose and aesculetin. Previously, S. uberis was divided into two
different serotypes, I and II, both having been isolated from cases of
bovine mastitis. The latter was reclassified as S. parauberis [6], while
all the S. uberis-like strains isolated from human cases were merged in
Globicatella sanguinis [3].
Among 1,894 isolates of aesculin-positive streptococci, 82.3% were
identified as S. uberis [7]; no data was provided on the origin of these
strains. On the other hand, some papers indicate that approx. 83% of
S. uberis isolates are also aesculin-positive [8,9], while others [10,11]
demonstrated that all strains are capable of hydrolysing aesculin.
When growing on blood agar plates, S. uberis displays either a weak α-
or γ-haemolysis [12]. Approx. 95% of S. uberis isolates are positive for
ß-galactosidase which can be used to tell them apart aesculin-
hydrolyzing enterococci. Watts et al. [13] recommended a modified
Rambach agar for identification on which S. uberis colonies grow with
a blue colour. In comparison, colonies of S. agalactiae, S. dysgalactiae,
Enterococcus (E.) saccharolyticus or E. faecalis do not metabolize
propylenglycol (red colonies) and do not produce β-galactosidase [13].
S. uberis produces acids out of cellobiose, aesculin, glucose, fructose,
galactose, inulin, maltose, mannitol, mannose, ribose, salicin, sorbitol,
starch, sucrose and trehalose [9]. Its growth was observed in 4%, but
neither in 6.5% NaCl nor at a pH of 9.6. Telling S. uberis from
enterococci is also possible applying the Sherman criteria. S. uberis
grows slowly or ceases to do so at ≤ 10°C and ≥ 45°C. Microorganisms
become inactivated after heating to 60°C for 30 minutes [12]. Recently,
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a scheme based on eleven biochemical tests was recommended to
identify S. uberis [9], i.e. the Christie-Atkins-Munch-Petersen reaction
(81% of tested S. uberis were negative), arginin hydrolysis (83%
negative), aesculin (89% positive) and sodium hippurate (96%
positive), growth in an inulin-containing medium (64% positive),
usage of mannitol (98% positive), raffinose (94% negative), salicin
(94% positive) and sorbitol (96% positive) as a source for
carbohydrates, growth at 45°C (98% negative) and in 6.5% NaCl
(100% negative).
S. uberis is a serologically heterogeneous species [12]. This is a key
fact to notice as this heterogeneity leads to marked differences
regarding the pathogen’s epidemiological properties [14]. It is not
possible to differentiate between S. uberis and S. parauberis, which was
described in the year 1990 [6] using phenotypic methods [4]. As
shown by Zadoks et al. [15], a few S. uberis strains isolated from milk
are closely related to S. parauberis. Species-specific primers for the
detection of S. uberis on species level via molecular probes reacting in
PCR are described by several authors [16,17]. Forsman et al. [16] used
the primer pair STRU-UbI and STRU-UbII (size of the main PCR
product: 330 bp) to detect S. uberis with a high degree of reliably,
while Riffon et al. [17] worked with the primers Sub 302, 396, 1546,
and 2170, based on GI no. 43370 and 2668550 (23S rDNA) in order to
design a culture-independent PCR diagnosis kit. Pulsed-field gel
electrophoresis and random amplified polymorphic DNA
fingerprinting are used to evaluate the diversity of strains of S. uberis
which in turn reflects its adaptability to the udder [18-20]. In addition,
multilocus sequence typing is used to characterize S. uberis
populations as well as the epidemiological properties of this pathogen
[21,22], i.e. the loci arc, ddl, gki, recP, ddk, tpi, yqiL, hasA, and hasC
(225 to 793 bp amplicon size).
Primers used for PCR include ub-I and ub-II (for the rRNA target
gene 16S), ub-23S-I and ub-23S-II (for 23S) as well as STRU-Ub-I and
STRU-Ub-II (for the 16S-23S intergenic spacer [23]).
Virulence factors
The factors of virulence are not known completely and it is
suggested that their expression varies from one strain to the other
[24,25]. S. uberis is able to adhere to and invade in mammary epithelia
cells [26-28]. Adherence and invasion can be attributed to the “S.
uberis adhesion molecule” (SUAM) [29]. According to Frost et al. [30],
the high prevalence of S. uberis in some dairy herds may be explained
by the ability to adhere to host cells. The enzymes of S. uberis seem to
affect strongly the dissemination of infections caused by it [28]. All
strains produce free hyaluronidase that enhances the distribution of
the pathogen within tissues [24,28]. According to Matthews et al. [26],
the hyaluronidase synthesized by S. uberis is capable of preventing the
proliferation of a line of udder epithelial cells. Another factor of
virulence could be its capability to produce hyaluronic acid capsules
[25]. Matthews et al. [25] indicated that 44% of S. uberis strains
isolated from bovine udders provoked these capsules. Crowley et al.
[31] showed that clinical isolates produce more biofilm biomass than a
strain from a healthy cow. S. uberis binds lactoferrin to obtain iron
required for bacterial growth [32]. Besides that, a plasminogen
activator factor and a CAMP factor have also been recorded [33]. In
fact, Tassi et al. [34] could show that S. uberis strains may also be
differentiated into host-adapted, pathogenic strains, and non-adapted,
basically apathogenic strains.
Epidemiology
Habitats and reservoirs
S. uberis is no mastitis pathogen that is obligatorily adapted to the
udder. In fact, it is a ubiquitous microorganism which colonizes
animals as well as their environment [35,36]. It has been localized on
the animals’ lips, tonsils and skin, inside the oral cavity, rumen,
respiratory tract, rectum, on the teat orifice, in teat canals and infected
udders, and in faeces and wounds. It appears that S. uberis spreads
mainly via the mucosae of the digestive tract. Starting from the oral
and lips mucosae, the pathogen is distributed via licking into the
environment, including fur and epidermis of other cows. Furthermore,
bovine faeces (and with that, the intestinal mucosa) also contribute
strongly to its dissemination in the environment [36-45]. Despite the
detection of S. uberis in bovine teat canals, it remains unclear if-unlike
cow-associated mastitis pathogens like Staphylococcus (S.) aureus and
S. agalactiae-the environmental-associated pathogen S. uberis is able to
colonize the teat canal epithelium [46-48].
Hejlicek [43] encountered S. uberis in 51.6% of dairy cow skin
samples and in 85.8% of environment samples. Zadoks et al. [15]
found that it was present in 63% of environment samples (i.e. earth,
vegetable material and bedding), in 23% of faeces samples and 4% of
milk samples. During summer (grazing season), bovine faeces are
more contaminated than in other seasons. Straw and other organic
bedding materials enhance the growth of S. uberis [36]. Furthermore,
approx. 20% of Canadian colostrum samples also contained S. uberis
[49]. Since samples were drawn from the drinking bottles, the exact
origin of these bacteria remains undetermined [49]. Furthermore, it is
hypothesized that flies may be a potential reservoir for S. uberis [50].
Infections originated during the dry period
The dry period is the most common portion of the production cycle
in which dairy cows acquire an infection with S. uberis [51,52].
Frequently S. uberis infections are manifested as acute mastitis, usually
during the subsequent lactation [46]. Wilkinson [53] calculated that
56% of clinical cases had originated during the dry period. If few
strains are found on a single farm, a contagious form is suspected. If
several cows of a herd were infected, it is relatively improbable that all
infections were caused by the same strain. Infections caused by one
dominating S. uberis strain are more persistent than those by several
minor strains.
Due to its biochemical abilities and the ability to invade in
mammary gland cells and to its capacity to produce biofilms and
capsule forming it was suggested that S. uberis can persist in infected
bovine udders. This promotes the development of chronic infections
of the mammary gland and allows the pathogen to turn from
environment-associated to cow-associated [54].
Intramammary infections and mastitis
Mammary epithelial cells are involved in inflammatory processes
[55,56]. In comparison to Escherichia (E.) coli, S. uberis induces a
delayed mRNA expression of interleukin-8 by epithelial cells [56]. This
cytokine is involved in the recruitement of neutrophils [57]. Tassi et al.
[31] observed that neutrophils, lymphocytes and interleukin-17A may
play roles in the healing of intramammary S. uberis infections.
Numerous authors stated that S. uberis produces clinical and
subclinical cases of mastitis [e.g. 58,59], being classified as an
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environment-associated, major pathogen. According to Hillerton and
Berry [60], environmental streptococci are responsible for one third of
clinical mastitis cases. S. uberis enters the udder via the teat canal, and
high bacterial counts in the environment raise the infection rate [35].
Reports on the duration of the infection vary considerably. While
most infections are relatively short (16 to 46 days; [19,61]), some
authors described prolonged periods from 2 to 20 months [43,62,63].
The infection rate of subclinically-diseased quarters seems to be
low, even in herds in which S. uberis is the most prevalent pathogen of
clinical mastitis. Accordingly, Tenhagen et al. [64] detected S. uberis in
only 1% of quarters sampled in the German federal state of
Brandenburg. Zadoks et al. [65] showed that in older cows, prevalence
increased with the lactation stage, while during early lactation, there
were no significant differences between primiparous and multiparous
cows.
On the contrary Piepers et al. [66] pointed out that aesculin-positive
cocci including S. uberis have become more important as cause of
subclinical mastitis. Analysing quarter-milk samples obtained from
Belgian dairy cows during cross-sectional dairy herd screenings
performed between 2000 and 2002, they found a herd prevalence of
aesculin-positive cocci of 2,6% (0-21,7%).
If S. uberis evolves to the leading pathogen of a dairy herd, frequent
antimicrobial treatments and a series of environment-associated
factors seem to promote the development of this type of mastitis
[67,68]. Clinical cases caused by S. uberis are closely associated with
hygiene conditions, feeding and machine-milking [69].
Teat and udder surface contamination between milkings is the first
step for the development of mastitis by S. uberis. Construction of the
resting areas, the available space per cow, the bedding material and its
frequency of renewing, cleaning and disinfection and the time the
animal spends in the cubicles are factors that determine the infection
between milkings [70]. Sources for S. uberis are found in loose
housing-as well as in pasture systems and also include water for
livestock. Increased bacterial counts in bedding materials contribute to
rising infection rates which are maximized during warm seasons
[61,71].
Previous and persisting infections favour new infections. After the
infection by S. uberis had healed, an increased risk of reinfection
(particularly by S. uberis) was observed [65]. The infection rates were
also increased if quarters were affected by Trueperella pyogenes,
enterococci or S. aureus.
Infections with minor pathogens such as Corynebacterium (C.)
bovis were thought, for a long time, to reduce the risk of becoming
affected by S. uberis. However, Hogan et al. [72] could demonstrate
that udder inflammations due to environmental streptococci were 3.9
times more frequent in quarters infected by C. bovis than in
uninfected ones; regarding staphylococci, the infection risk increased
by the factor 2.6. To explain this difference to the common
assumption, the authors referred to the elevated sampling frequency
and to the fact, that 69% of infections with S. uberis last fewer than 30
days.
Apart from the transmission by means of the contamination of teat
and udder skin between milkings, Zadoks et al. [50] suggested a
contagious way of transmission. The pathogen could be detected in a
milk swab sample from a liner rubber directly after milking a cow
infected with S. uberis [18]. Chronically affected animals could
contribute particularly to the transmission of the bacterium during
milking [73]. As stated above, S. uberis could also be isolated from the
oral cavity, so that reciprocal sucking of the teats might also pose one
risk of infection [74]. According to Smith et al. [71], the new infection
rate rises by the factor of 5 between the first and the fourth lactation.
The results of Zadoks et al. [65] support these finding by stating that
the infection rate regarding environmental streptococci is lower in
animals of the first and second lactation than in older animals.
Zadoks et al. [65] did not found a relation between teat end
roughness and S. uberis mastitis. In contrast, Breen et al. [75] showed
that very rough callous rings increase the risk of clinical S. uberis
mastitis. Furthermore, the absence of callous rings may be associated
with an increased mastitis risk. Paduch et al. [48] could show that the
teat canal microbial load of S. uberis is associated with teat end
hyperkeratosis. In the study of Moyes et al. [76] regarding the negative
energy balance, udders were infected experimentally with S. uberis.
One result was that most genes necessary for the modulation of an
immune response were suppressed in the case of animals that
presented a negative energy balance. However, no significant
associations between body condition score (BCS) and infection rate
[65] or clinical mastitis risk [75] for S. uberis were found. No further
details are known regarding the specific interaction between this
pathogen and tissue damages produced by inadequate machine
milking except that there is a relation between the degree of
hyperkeratosis of the teat tip and the microbial load of S. uberis [48].
Control of S. uberis
Implementing the five-point-plan developed by Bramley and Dodd
[46] to control contagious mastitis (i.e. teat disinfection after milking,
dry-off using antibiotics, culling of animals resistant to therapy,
therapy of clinical mastitis, maintenance and correct application of the
milking machine) affects udder health only marginally in cases where
the pathogen is environment-associated [77]. This implies that
treatment measures only are not enough to improve the situation of
infections.
The goal is rather to minimize the exposure of the teat canal to S.
uberis. This is obtained by an optimisation of the environment
hygiene and the udder preparation. Concerning the latter however, it
remains unclear what precisely improves the status of the infection.
Hogan et al. [72] focused on the inhibiting interaction between S.
uberis and C. bovis (see above), which would suggest that a high
degree of hygiene at milking may reduce the colonization of the teat
skin with environment streptococci and C. bovis alike. Thus, the
protective effect of C. bovis would be diminished (as would be the risk
of getting infected via teat skin contamination). An udder preparation
including humidified, single-use udder towels or a pre-dipping with
0.1% iodophor solution can achieve a significant reduction of the
infection rate [78], with pre-dipping being more effective than udder
towels soaked in water.
Teat disinfection after milking reduces the prevalence of new
infections with S. agalactiae and S. aureus, but not that of other
streptococci [79].
Godinho and Bramley [80] investigated the efficiency of post-
milking, dipping disinfectants containing ethanol, iodophores or
chlorhexidin on teats which previously had been contaminated with S.
uberis and Escherichia coli. All substances displayed a bactericidal
effect, but the persistency of this effect on the teat surface varied.
According to this study, a long persistence is beneficial to control
environmental pathogens.
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The cows‘ coat may be contaminated with S. uberis and, since
reciprocal licking is part of the social behaviour of the animals, the
pathogen may be distributed readily from one animal to another.
Clipping the udder of the animals reduces the surface available for
pathogens, and frequent clipping was associated with low bulk SCC
[69]. The same is true for providing clean water for drinking. Zadoks
et al. [14] encountered S. uberis in water and faeces at irregular
intervals, so an oral infection seems possible.
Improving the hygienic conditions of the cows also includes the
maintenance of the cubicles and the choice of an adequate bedding
material. Zadoks et al. [50] postulated that bedding management may
play a role in outbreaks of S. uberis mastitis. As stated by Hughes [52],
S. uberis is not able to grow in bedding materials at pH values above
9.5. Paduch et al. [45] showed that the alkalisation of sawdust bedding
reduces teat skin bacterial counts of S. uberis. However, associations
between the alkalisation and teat canal bacterial counts could not be
found for S. uberis. In general, environmental pathogens like S. uberis
and E. coli could be controlled by teat cleaning before milking and
housing and bedding management practices [81].
If reducing the risk of exposition is one way to reduce the new
infection rate, improving the immune status of the animals is another
one. As concluded by O’Rourke [81], deficiencies in nutrition are
generally associated with the suppression of the immune system which
promotes the risk of clinical mastitis. According to a study of
Todhunter et al. [61], approx. 50.5% of intramammary infections
initiate during the dry period, just as Smith et al. [71] recorded more
infections during dry period than during lactation. Applying dry cow
treatment is effective to reduce the number of infections by S. uberis,
especially during the first quarter of the dry period [71]. Therefore, in
order to maintain a high level of protection also during the rest of the
period, measures beyond drying-off with antibiotics will be necessary.
Prepartum teat disinfection with an iodophore dip alone however was
not sufficient [82].
Cattell [73] in turn claimed that S. uberis as a herd problem
originates from a bad choice of dry-off substance and omitting to treat
clinical cases. This leads to chronic infections that serve as a reservoir
for reinfection which ultimately will increase the presence of the
pathogen in the environment. To cope with the latter, the author
recommends thorough stripping extraction including a control of this
secretion, an adaption of the dry management and the treatment of
clinical cases during lactation.
Therapy
Typically, penicillin-based products are used to treat udders
affected by S. uberis, although in some areas, only 75% of strains are
still sensible towards them [43]. Macrolides and cephalosporins are
used as an alternative. In Northern Germany, a survey regarding the
antimicrobial resistance patterns of pathogens from quarter foremilk
samples between 2004 and 2010, no in vitro resistance was found
towards penicillin, ampicillin, oxacillin, cefquinome, amoxicillin/
clavulanic acid nor cefazolin. Resistance against cefoperazone was
<1%, against pirlimycin and erythromycin approx. 30%, and the
percentage of strains resistant against tetracyclins rose from <1 to
>50% [83].
Treating subclinical cases during lactation lead to a reduction of the
somatic cell counts, but animals remain more susceptible towards
reinfections. This is why treatments during the lactation are
recommended for clinical cases only [84].
As S. uberis colonizes the ducts before spreading into the mammary
parenchyma, intra-cisternal treatment is the treatment of choice.
While Sandgren et al. [84] could not find any statistical difference
between parenteral and local treatments (five days each), Hillerton and
Kliem [85] were able to obtain the best results by applying a sufficient
dose of antibiotics intra-cisternally over a prolonged time. Another
study [86] treated clinical mastitis due to streptococci using either
parenteral applications of penethamate hydroiodine or a combination
of cloxacillin and ampicillin locally, each for three days. The
bacteriological healing rates were 71 and 74%, resp., i.e. comparable
values to those obtained by Hillerton and Kliem [85]. Although these
rates did not differ significantly, the parenteral application lead to a
reduction of high somatic cell counts in adjacent, culture-negative
quarters.
Several studies demonstrated that the extension of the therapy is
advantageous [85,87-90]. Oliver et al. [88,90] investigated the effect of
time using the third-generation cephalosporin ceftiofur to treat S.
uberis mastitis for two, five, and eight days. Bacterial cure rates for
naturally-occurring, subclinical cases were to 17, 56, and 67%, resp.
(no significant differences), while for experimental infections treated
intra-cisternally, values were 43, 88 and 100%, respectively. However,
in the last trial the somatic cell counts were only reduced when a
bacteriological cure had actually taken place.
Hillerton and Kliem [85] also infected cows experimentally with
this pathogen. If the clinical cases were left untreated, parenchyma
tissue damage was extreme and lead to the loss of the given quarter. If
an intensive local treatment (three days, twice a day) was initiated,
clinical cure rates amounted to 70% (after three days) and even 100%
(after six days). Using a similar design (but with procaine penicillin
and dihydrostreptomycin applied parenterally) lead to clinical cure
rates of 18 and 91%, respectively. Bacteriological cure was obtained in
80% of quarters in both designs. By combining local and parenteral
treatment, clinical cure rates were 61 and 100%, respectively. However,
the bacteriological cure rate of 72% ranged below the values obtained
for the single treatments. One intra-cisternal application per day over
a period of three days reduced clinical (27 and 91%, resp.) and
bacteriological cure rates (64%) alike.
Administering oxytocin intramuscularly twice a day for three days
as an alternative did not produce any clinical cure, neither alone nor in
combination with a once-a-day intra-cisternal treatment with
antibiotics. Even after six days, this treatment combination only
yielded 10% of clinical healing.
McDougall et al. [91] applied 5 g tylosin base daily for three days
and obtained a bacteriological healing in 89.8% of quarters. 87.7% of
quarters were healed if 5 g of penethamate hydroiodine were used
instead; results did not differ significantly.
Cattell et al. [92] applied lincosamides (pirlimycin hydrochlorine)
daily for two days into the cistern to treat clinical and subclinical
mastitis due to streptococci and obtained bacteriological cure rates of
48% (cow level) and 70% (udder level).
As demonstrated by Hillerton and Kliem [85], applying oxytocin
alone to treat clinical cases by S. uberis is unsatisfactory. 20 IU of this
hormone administered to cows with a suspected case of mastitis
eliminated 25% of cases; thus, 75% of animals still developed clinical
mastitis [93]. Comparing three consecutive intracisternal applications
of antibiotics (at each milking time i. e. over a period of 1,5 days) with
10 applications (i. e. over a period of 5 days) the prolonged treatment
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regimen leads in cases of moderate an severe clinical mastitis cases to
higher bacteriological and cytological cleaning rates [89].
In a study of Roberson et al. [94] frequent milk-out appeared to be
detrimental for managing mild to moderate clinical mastitis caused by
environmental streptococci.
Dry cow treatment
As stated above, new infections are most frequent during the dry
period, and dry-off treatment leads to a marked reduction of problems
during the first phase of the dry period. Cure rates of 87 to 95% were
observed when administering semi-synthetic penicillins [43]. Yet, the
last two weeks remain unprotected (in many cases, the teat canal open
up, the keratin plug gets lost and the periparturient immune
suppression commences).
Usage of dry cow antibiotics plays an important role in the
reduction of mastitis incidence due to S. uberis. In a study of
Williamson et al. [59] the administration of a dry cow antibiotic to
uninfected quarters reduced the incidence of new infections with S.
uberis from 12.3% (untreated quarter) to 1.2% (treated quarter). This
reduction was significant for dry-period as well as post-calving
infections.
Furthermore the usage of external or internal teat sealer should
lower the infection rate with environmental germs like S. uberis and E.
coli. Lim et al. [95,96] showed that the efficiency of an external teat
sealer varies with the time frame of adherence (longer adherence on
longer teats, in cold climate or after double application). In the review
of Rabiee and Lean [97], internal teat sealer alone or in combination
with antibiotic dry cow therapy reduced the risk of acquiring new
intramammary infections after calving by 25%. Compared with
untreated cows, internal teat sealer reduced the risk by 73% although
there could be stated a huge heterogeneity in the results. The reduction
of clinical mastitis was calculated with 29% and 48%.
Vaccination
Since Hill [98] showed that previous exposure to S. uberis could
provide some resistance to infection against the same strain, several
trials with a broad variety in efficiency were performed to identify
potential vaccine candidates against S. uberis mastitis: i. e. the
plasminogen activator PauA as a total antigen as well as a PauA
depleted antigen [99], recombinant S. uberis GapC or a chimeric
CAMP antigen [100], recombinant S. uberis adhesion molecule [101]
as well as S. uberis bacterin [102] etc. Until now there is still a lack of
vaccine which is able to control infection without the participation of a
marked inflammatory response.
Conclusion
Controlling S. uberis-infections remains an important task. The
germ is commonly found in manure and other organic matter.
Inadequate stall or pasture management e. g. dirty and wet bedding
material or muddy areas as well as inproper milking procedures lead
to an increased infection risk. As infections are difficult to cure,
emphasis needs to be placed on prevention of these infections. Still
further research is necessary to allow a ranking of management
methods regarding their efficiency to reduce contamination with these
bacteria.
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